Saw Palmetto En Banc Appeals Court Re-Hearing Requested
This article was originally published in The Tan Sheet
Executive Summary
A group of supplement marketers seeking approval of a health claim linking saw palmetto to treatment of benign prostatic hyperplasia have filed a petition for an en banc rehearing with the U.S. Court of Appeals